IMMATURE PLATELET FRACTION AS A BIOMARKER OF SEPSIS IN ACUTE MYELOID LEUKEMIA PATIENTS RECEIVING CHEMOTHERAPY
Last updated: 26 Dec 2024
10.21608/alexpo.2021.110355.1326
Acute myeloid leukemia (AML), Sepsis-3, IMMATURE PLATELET FRACTION
Ashraf
El Ghandour
Hussein
Department of Internal Medicine (Hematology Unit), Faculty of Medicine , Alexandria University
ashraf.elghandour@gmail.com
Nadia
Zaki
El Sayed
Department of Internal Medicine (Hematology Unit), Faculty of Medicine , Alexandria University
nadiazaki56@yahoo.com
Mona
Helmy
Wagdy
Department of Clinical and Chemical Pathology, Faculty of Medicine Alexandria University
monawagdy16@yahoo.com
Alex
Eman
Nadwan
Attia
Department of Internal Medicine (Hematology Unit), Faculty of Medicine , Alexandria University
eman.nadwan@alexmed.edu.eg
Hanaa
Donia
Department of Clinical Pathology, Faculty of Medicine , Alexandria University
hanaadonia@gmail.com
Alaa
Kamel
AbdElhady Mohamed
Department of Internal Medicine (Hematology Unit), Faculty of Medicine , Alexandria University
drlola127@gmail.com
3
4
28719
2021-12-01
2021-12-09
2021-12-01
103
104
2682-2636
https://alexpos.journals.ekb.eg/article_210028.html
https://alexpos.journals.ekb.eg/service?article_code=210028
1
Preliminary preprint short reports of original research
1,426
Journal
ALEXMED ePosters
https://alexpos.journals.ekb.eg/
IMMATURE PLATELET FRACTION AS A BIOMARKER OF SEPSIS IN ACUTE MYELOID LEUKEMIA PATIENTS RECEIVING CHEMOTHERAPY
Details
Type
Article
Created At
23 Jan 2023